These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8760710)

  • 1. Antenatal screening for cystic fibrosis.
    Cuckle H; Quirke P; Sehmi I; Lewis F; Murray J; Cross D; Cuckle P; Ozols B
    Br J Obstet Gynaecol; 1996 Aug; 103(8):795-9. PubMed ID: 8760710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal screening for cystic fibrosis: a trial of the couple model.
    Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
    BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
    Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
    BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of antenatal screening for cystic fibrosis.
    Cuckle HS; Richardson GA; Sheldon TA; Quirke P
    BMJ; 1995 Dec; 311(7018):1460-3; discussion 1463-4. PubMed ID: 8520332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis carrier testing in early pregnancy by general practitioners.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    BMJ; 1993 Jun; 306(6892):1580-3. PubMed ID: 8329921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active cascade testing for carriers of cystic fibrosis gene.
    Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
    BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
    Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
    J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
    Jung U; Urner U; Grade K; Coutelle C
    Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise or couple antenatal carrier screening for cystic fibrosis?: women's preferences and willingness to pay.
    Miedzybrodzka Z; Semper J; Shackley P; Abdalla M; Donaldson C
    J Med Genet; 1995 Apr; 32(4):282-3. PubMed ID: 7643357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for carriers of cystic fibrosis among pregnant women: a pilot study.
    Schwartz M; Brandt NJ; Skovby F
    Eur J Hum Genet; 1993; 1(3):239-44. PubMed ID: 8044649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-effectiveness of prenatal carrier screening for cystic fibrosis.
    Lieu TA; Watson SE; Washington AE
    Obstet Gynecol; 1994 Dec; 84(6):903-12. PubMed ID: 7970468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot study of the acceptability of cystic fibrosis carrier testing during routine antenatal consultations in general practice.
    Harris H; Scotcher D; Hartley N; Wallace A; Craufurd D; Harris R
    Br J Gen Pract; 1996 Apr; 46(405):225-7. PubMed ID: 8703524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Screening for carriers of cystic fibrosis. Result of a pilot study among pregnant women].
    Brandt NJ; Schwartz M; Skovby F
    Ugeskr Laeger; 1994 Jun; 156(25):3751-4, 3757. PubMed ID: 8059452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based genetic carrier screening for cystic fibrosis in Victoria.
    Archibald AD; Massie J; Smith MJ; Dalton DG; du Sart D; Amor DJ
    Med J Aust; 2014 Mar; 200(4):205-6. PubMed ID: 24580517
    [No Abstract]   [Full Text] [Related]  

  • 16. CFTR DeltaF508 mutation detection from dried blood samples in the first trimester of pregnancy: a possible routine prenatal screening strategy for cystic fibrosis?
    Konialis CP; Hagnefelt B; Kazamia C; Karapanou S; Pangalos C
    Fetal Diagn Ther; 2007; 22(1):41-4. PubMed ID: 17003555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. UK Cystic Fibrosis Follow-Up Study Group.
    Axworthy D; Brock DJ; Bobrow M; Marteau TM
    Lancet; 1996 May; 347(9013):1443-6. PubMed ID: 8676627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for cystic fibrosis.
    Mennie ME; Gilfillan A; Compton M; Curtis L; Liston WA; Pullen I; Whyte DA; Brock DJ
    Lancet; 1992 Jul; 340(8813):214-6. PubMed ID: 1353143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost comparison of different methods of screening for cystic fibrosis.
    Morris JK; Oppenheimer PM
    J Med Screen; 1995; 2(1):22-7. PubMed ID: 7497140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.
    Haddow JE; Bradley LA; Palomaki GE; Doherty RA
    J Med Screen; 1999; 6(2):60-6. PubMed ID: 10444721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.